chronic hepatitis B

7 · 20 / page

Ask MedXY AI

Latest news

Tag

Gastroenterologychronic hepatitis BHBsAg seroclearance

Long-term Risk of Hepatocellular Carcinoma After Clearance of Hepatitis B Surface Antigen

By MedXY|Jul 14, 2026

This study evaluates the long-term incidence of liver cancer in chronic hepatitis B patients who clear hepatitis B surface antigen, finding significantly reduced cancer risk in younger patients without cirrhosis.

Functional Anti-preS1 Antibody Responses and Their Role in Viral Control in Chronic Hepatitis B

Clinical Updateschronic hepatitis BHBV therapy

chronic hepatitis B

Latest news

Long-term Risk of Hepatocellular Carcinoma After Clearance of Hepatitis B Surface Antigen

Functional Anti-preS1 Antibody Responses and Their Role in Viral Control in Chronic Hepatitis B

HBsAg Seroclearance Lowers Hepatocellular Carcinoma Risk Beyond Viral Suppression in Cirrhosis, but Does Not Reduce Hepatic Decompensation

Potent Viral Suppression and Safety of ALG-000184: Insights from a Phase 1 Trial in Chronic HBV Infection

Functional Cure Within Reach: GSK’s Bepirovirsen Meets Primary Endpoints in Pivotal Phase III Chronic Hepatitis B Trials

Elebsiran Combined with Pegylated Interferon Alfa for Chronic Hepatitis B: Advances from Phase 2 Clinical Trials

Sequential Pegylated Interferon after Bepirovirsen Lowers Relapse Risk in Chronic Hepatitis B: Insights from the B-Together Trial